"Enabling Genomics in Routine Medical Care"
About the Company:
DxTerity is dedicated to expanding the use of genomic testing in routine medical care. A deep understanding of the genetic mechanisms underlying disease is the key to a coming revolution in clinical management and treatment. Genomic information is becoming indispensable to medical practitioners – not just for detecting and diagnosing disease, but for accurately guiding treatment.learn more…
About the Technology:
Despite its immense potential, complex genomic testing has faced barriers to widespread use because it is simply too expensive and complex for widespread adoption in clinical practice – until today. DxTerity is changing that paradigm by making genomic testing simple, fast, and affordable with its revolutionary DxDirect™ technology.learn more…
Recent News
DxTerity Presents DxDirect Work Flow Advantages at AMP October 25th 2012 read More...
DxTerity Launches REDI-Dx RUO for Acute Radiation Exposure read more...
DxTerity Presents Direct from Sample Mulitplex Gene Expression in Tissue and FFPE to the American Association of Cancer Researchers read more...